The official unveiling of the much awaited Antalgex T combination of Paracetamol 325 mg and Tramadol hydrochloride 37.5 mg took place in Abia State recently, with Dr Okezie Ikpeazu, Abia State governor; Pharm. Ahmed Yakasai, president of the Pharmaceutical Society of Nigeria (PSN) and Dr Monica Hemben-Eimunjeze, director of regulatory affairs, NAFDAC, in attendance.
The launch, held during the opening ceremony of the just concluded 90th annual Conference of the Pharmaceutical Society of Nigeria (PSN) at International Conference Centre, Umuahia, Abia State, was streamed live on social media and witnessed by over 2,000 pharmacists seated in the hall.
Antalgex T, one of the marque products of Exphar Lab Limited recently introduced into the Nigerian Pharmaceutical market, is indicated for the symptomatic treatment of moderate to severe pain.
In his presentation on pain management, Pharm. Baptiste Deffrennes, regulatory affairs officer, Exphar S.A. Belgium, described pain as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.
Speaking further, Deffrennes noted that aside from being a defence mechanism of every organism, the role of pain is to support healing and recovery.
“According to the WHO, the antalgic effects of tramadol result from both morphinic and anoradrenergic/serotoninergic effects. Tramadol has multiple modes of action, interacting with several features of the pain pathways.
“Therefore the combination of both analgesics (paracetamol and tramadol) at half doses led to a supra-additive pain reduction and enhanced the antihyperalgesic effect as compared to a single administration of paracetamol,” he declared.
Shortly after unveiling the product to the public, Yakasai congratulated both the management of Exphar Lab and its parent company in Belgium for the innovative product launch.
Also endorsing the product, Governor Ikpeazu pledged that it would receive the attention of the state ministry of health.
Other dignitaries at the product launch included Anne-Marie Martinez, chief executive officer, Exphar S.A. Belgium; Pharm. Emma Ilozor, managing director, Exphar Lab Limited and Koen Smessaert, administrator
Antalgex T is marketed in Nigeria by Bolar Pharmaceutical Limited.